Search results for " Immunodeficiency"

showing 9 items of 309 documents

CD4saurus Rex & HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution.

2011

Abstract One of the most neglected areas of everyday clinical practice for HIV physicians is unexpectedly represented by CD4 T cell counts when used as an aid to clinical decisions. All who care for HIV patients believe that CD4+ T cell counts are a reliable method to evaluate a patient immune status. There is however a fatalistic acceptance that besides its general usefulness, CD4+ T cell counts have relevant clincal and immunological limits. Shortcomings of CD4 counts appear in certain clinical scenarios including identification of immunological nonresponders, subsequent development of cancer on antiretroviral teatment, failure on tretment simplification. Historical and recently described…

medicine.medical_specialtyT cellantiviral treatmentHuman immunodeficiency virus (HIV)lcsh:MedicineHIV; AIDS; CD4Diseasemedicine.disease_causeGeneral Biochemistry Genetics and Molecular BiologyCD4+T cellsImmune systemAcquired immunodeficiency syndrome (AIDS)medicineIntensive care medicineMedicine(all)clinical trialsImmune statusBiochemistry Genetics and Molecular Biology(all)business.industrylcsh:RCancerimmune reconstitutionGeneral Medicinemedicine.diseaseClinical trialmedicine.anatomical_structureImmunologyCommentarybusiness
researchProduct

Chirurgie und AIDS

2009

medicine.medical_specialtyText miningAcquired immunodeficiency syndrome (AIDS)business.industryGeneral surgerymedicineMEDLINEGeneral MedicineSurgical proceduresbusinessmedicine.diseaseDMW - Deutsche Medizinische Wochenschrift
researchProduct

Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients

2013

Adverse drug reactions to highly antiretroviral therapy (HAART) are major obstacles in its success. Although overall mortality from HIV has dramatically declined owing to HAART, these antiretroviral regimens have been associated with a wide spectrum of severe cutaneous reactions. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. To optimize adherence and efficacy of antiretroviral treatment, clinicians must focus on preventing adverse effects whenever possible, and distinguish those that are self-limited from those that are potentially serious. This paper presents the case of a serious cutaneous adverse reaction to Atripla in a HIV-positive 50-…

medicine.medical_specialtybusiness.industryHuman immunodeficiency virus (HIV)Adverse drug reactionAdverse drug reactionsHIVDermatologylcsh:RL1-803medicine.disease_causeAntiretroviral therapyPublished online: May 2014Surgerylcsh:DermatologymedicineAntiretroviral treatmentSettore MED/35 - Malattie Cutanee E VenereeDrug reactionIntensive care medicinebusinessAdverse effectHighly antiretroviral therapySkin
researchProduct

The immune response behavior in HIV-AIDS patients treated with ozone therapy for two years

2018

HIV continues to be one of the biggest problems for the global public health. The African region is one of the most affected, accounting for almost two thirds of the new infections. Many of them are retroviral medications and multi-therapies aiming to stop the viral replication and maintaining immunological stability, which fail to guarantee the quality of life or enhance the patient's immunity
 Ozone has biological properties, among which the antimicrobial and modulatory effect on the immune response is highlighted, which makes it possible to use it in a complementary way for the treatment of these patients.
 We conducted the present study in which the effect of the ozone therapy…

medicine.medical_specialtybusiness.industrymedicine.diseaseOzone therapyAntimicrobial:CIENCIAS MÉDICAS [UNESCO]AutohemotherapyImmune systemAcquired immunodeficiency syndrome (AIDS)ImmunityInternal medicineUNESCO::CIENCIAS MÉDICASmedicinebusinessViral loadCD8
researchProduct

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study

2020

INTRODUCTION Coronavirus disease 2019 (COVID-19) caused by SARS-CoV2 virus is thought to be more severe in patients with prior hematological diseases. There is evidence suggesting that hematological patients are particularly vulnerable and have a higher risk of developing severe events, with higher mortality rate than general population. However, the available data are limited, and prognostic factors at admission still remain unclear. With this background, our aims were to analyze the impact of hematological diseases and their therapy on the COVID-19 severity and to identify clinical and biological risk factors to predict the outcome in these patients. METHODS We carried out a multicenter …

medicine.medical_specialtyeducation.field_of_studybusiness.industryMortality rateImmunologyPopulation203.Lymphocytes Lymphocyte Activation and Immunodeficiency including HIV and Other InfectionsRetrospective cohort studyCell BiologyHematologyDiseasemedicine.diseaseBiochemistryComorbidityMulticenter studyInternal medicineIntensive caremedicineIn patienteducationbusinessBlood
researchProduct

Control de la dislipemia en grupos clínicos especiales: mujeres, ancianos, VIH, enfermedad renal crónica, pacientes con síndrome metabólico

2011

There is still some disagreement about how dyslipidemia should be treated in particular population groups. This article provides a review of indications for lipid-lowering treatment, preferably for primary prevention, in specific groups of patients: women, the elderly, and those with an HIV infection, chronic kidney disease or metabolic syndrome. Special emphasis is placed on data obtained in the JUPITER trial and in other studies of rosuvastatin.

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationHuman immunodeficiency virus (HIV)medicine.disease_causemedicine.diseaseInternal medicineJUPITER trialPrimary preventionmedicineRosuvastatinMetabolic syndromeCardiology and Cardiovascular MedicinebusinesseducationDyslipidemiamedicine.drugKidney diseaseRevista Española de Cardiología Suplementos
researchProduct

Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men

2018

Background Identifying determinants for histologically proven high-grade anal intraepithelial lesions (hHSIL) in HIV-positive MSM would allow better targeted screening. Methods APACHES is a prospective study of anal HPV and related-lesions in 513 HIV-positive MSM aged ≥35 in six clinics across France. At baseline, participants underwent high resolution anoscopy (HRA) with biopsy of suspicious lesions, preceded by anal swabs for liquid-based cytology, p16/Ki67 immunostaining, and HPV DNA. hHSIL diagnosis was established by histopathological review panel consensus, and determinants assessed by logistic regression. Results Baseline hHSIL prevalence was 10.4% and did not differ significantly by…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryHuman immunodeficiency virus (HIV)medicine.diseasemedicine.disease_causeLogistic regressionlcsh:Infectious and parasitic diseasesLesionInfectious DiseasesVirologyInternal medicineCytologyBiopsymedicinelcsh:RC109-216medicine.symptomProspective cohort studybusinessAscusImmunodeficiencyPapillomavirus Research
researchProduct

Prevalence and Risk Factors for Anal Human Papillomavirus Infection in Human Immunodeficiency Virus–Positive Men Who Have Sex with Men

2018

A correction has been published:The Journal of Infectious Diseases, Volume 218, Issue 8, 15 October 2018, Page 1350, https://doi.org/10.1093/infdis/jiy315; International audience; Background:We assessed prevalence and risk factors for anal human papillomavirus (HPV) in human immunodeficiency virus (HIV)-positive men who have sex with men (MSM), who are at high-risk of HPV-related anal cancer.Methods:APACHES is a multicentric, prospective study of anal HPV infection and lesions in HIV-positive MSM aged ≥35 years. At baseline, participants underwent anal swabs for HPV and cytology, plus high-resolution anoscopy. High-risk HPV (HR-HPV) was tested by Cobas4800, with genotyping of HR-HPV positiv…

medicine.medical_specialtymen who have sex with menMen who have sex with men03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyAnal cancer030212 general & internal medicineanal canalProspective cohort studyhuman papillomavirusGenotypinghigh-resolution anoscopy[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologymedicine.diagnostic_testhuman immunodeficiency virusbusiness.industryHPV infectionAnoscopyvirus diseasesOdds ratio16. Peace & justicemedicine.diseaseConfidence intervalfemale genital diseases and pregnancy complications3. Good healthInfectious Diseases030220 oncology & carcinogenesisbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Influence of sexual sensation seeking, sexual compulsivity and sexual pleasure in condom use among Spanish youth: implications for HIV interventions

2016

Spain is one of the countries with the highest incidence of HIV within the European Union. Multiple and complex factors influence HIV infection in young people. This study aims to determine the influence of sexual sensation seeking, sexual compulsivity and perceived sexual pleasure variables in condom use. A total of 424 heterosexual youth were evaluated (M age = 20.62; SD = 2.62) distributed into a risk group (60.7%) and a no-risk group (39.3%). Sexual Sensation Seeking Scale, AIDS Prevention Questionnaire, Sexual Compulsivity Scale, and Sexual Pleasure Perceived Scale were administered. Results indicate statistically significant differences in sexual sensation seeking (p=.001), failure to…

sexual compulsivityPsychological interventionHuman immunodeficiency virus (HIV)condom usemedicine.disease_causelaw.inventionDevelopmental psychologySexual compulsivitySexual pleasureCondomAcquired immunodeficiency syndrome (AIDS)lawmedicineSensation seekingsexual sensation seekingSidayouthbiologyHIV interventionsSexualitat (Psicologia)biology.organism_classificationmedicine.diseasesexual pleasurePsychologyClinical psychology
researchProduct